Related Experiment Video
Updated: Jun 16, 2026
08:27
Synthesis and Characterization of mRNA-Loaded PolyBeta Aminoesters Nanoparticles for Vaccination Purposes
Published on: August 13, 2021
4.5K
The mRNA vaccine platform for veterinary species
Fatemeh Fazel1, Janan Shoja Doost1, Sugandha Raj1
1Department of Pathobiology, Ontario Veterinary College, University of Guelph, Guelph, Ontario N1G 2W1, Canada.
Veterinary Immunology and Immunopathology
|July 14, 2024
Summary
Messenger RNA (mRNA) vaccines offer a promising, adaptable platform for veterinary medicine, addressing gaps in animal disease control and emerging threats. This technology is crucial for developing rapid responses to novel pathogens impacting animal and human health.
Area of Science:
- Veterinary immunology and vaccinology
- Emerging infectious diseases in animals
- Molecular vaccine technology
Background:
- Traditional veterinary vaccines have significantly improved animal health and production since the 19th century.
- Existing vaccines are ineffective against certain pathogens, like African swine fever, and emerging/re-emerging diseases pose ongoing threats.
- The SARS-CoV-2 pandemic underscored the need for adaptable vaccine platforms capable of rapid modification against evolving pathogens.
Purpose of the Study:
- To review recent advancements in messenger RNA (mRNA) vaccine technology for veterinary applications.
- To discuss the development, delivery methods, and efficacy of various mRNA vaccines in animal species.
- To explore the limitations and future potential of mRNA vaccines in veterinary medicine.
Main Methods:
- Comprehensive literature review of recent scientific publications on veterinary mRNA vaccines.
- Analysis of data concerning the development, formulation, and delivery systems for mRNA vaccines.
- Evaluation of reported efficacy studies for mRNA vaccines against various animal pathogens.
Main Results:
- mRNA vaccines have demonstrated efficacy against a range of viral and bacterial pathogens in preclinical and clinical veterinary studies.
- Various delivery methods are being explored to optimize mRNA vaccine stability, targeting, and immunogenicity in animals.
- The adaptability of mRNA platforms allows for rapid design and production, crucial for responding to emerging animal diseases.
Conclusions:
- mRNA vaccine technology represents a significant advancement with the potential to address unmet needs in veterinary disease control.
- Further research is required to overcome current limitations, optimize delivery systems, and ensure broad applicability across diverse veterinary species.
- mRNA vaccines are poised to play a critical role in safeguarding animal health and mitigating zoonotic disease risks.
Related Concept Videos
01:51Vaccinations
Overview
02:28Leaky Scanning
During most eukaryotic translation processes, the small 40S ribosome subunit scans an mRNA from its 5' end until it encounters the first start AUG codon. The large 60S ribosomal subunit then joins the smaller one to initiate protein synthesis. The location of the translation initiation is largely determined by the nucleotides near the start codon as there may be multiple translation initiation sites present on the mRNA. Marilyn Kozak discovered that the sequence RCCAUGG (where R stands for...
01:20The Central Dogma
The central dogma explains the flow of genetic information from DNA nucleotides to the amino acid sequence of proteins.
RNA is the Missing Link Between DNA and Proteins
In the early 1900s, scientists discovered that DNA stores all the information needed for cellular functions and that proteins perform most of these functions. However, the mechanisms of converting genetic information into functional proteins remained unknown for many years. Initially, it was believed that a single gene is...
RNA is the Missing Link Between DNA and Proteins
In the early 1900s, scientists discovered that DNA stores all the information needed for cellular functions and that proteins perform most of these functions. However, the mechanisms of converting genetic information into functional proteins remained unknown for many years. Initially, it was believed that a single gene is...
01:29Microorganisms in Medicine and Therapeutics
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
01:23Vaccine Production
Vaccine production involves a sequence of upstream and downstream processes to generate a safe and effective immunological product. It begins with cultivating microorganisms, such as viruses or bacteria, to obtain antigenic material. For viral vaccines, mammalian host cells are grown in bioreactors and subsequently infected with the target virus. The virus replicates within the host cells, which are lysed to release viral particles. This lysate is then clarified through filtration or...
01:21Vaccines
Vaccines are among the most effective tools in preventive medicine, designed to prepare the immune system to recognize and combat infectious agents. By introducing antigens—substances that the immune system identifies as foreign—vaccines stimulate an adaptive immune response that leads to immunological memory. This immunological memory enables the body to mount a faster and more effective response upon future exposures to the actual pathogen.Vaccines can be categorized based on the type of...